Display options
Cite
Ji H, Li H, Zhang H, et al. Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway. Mol Med Rep. 2021;25(1)doi: 10.3892/mmr.2021.12517.
Ji, H., Li, H., Zhang, H., & Cheng, Z. (2022). Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway. Molecular medicine reports, 25(1), . https://doi.org/10.3892/mmr.2021.12517
Ji, Hui, et al. "Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway." Molecular medicine reports vol. 25,1 (2022). doi: https://doi.org/10.3892/mmr.2021.12517
Ji H, Li H, Zhang H, Cheng Z. Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway. Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12517. Epub 2021 Nov 02. PMID: 34726254; PMCID: PMC8600399.
Copy Download .nbib Format: NLM
Share it on

Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12517. Epub 2021 Nov 02.

Role of microRNA‑218‑5p in sevoflurane‑induced protective effects in hepatic ischemia/reperfusion injury mice by regulating GAB2/PI3K/AKT pathway.

Molecular medicine reports

Hui Ji, Hui Li, Haixia Zhang, Zhijun Cheng

Affiliations

  1. Department of Anesthesiology, Xinhua Hospital, Chongming Branch, Shanghai 202150, P.R. China.

PMID: 34726254 PMCID: PMC8600399 DOI: 10.3892/mmr.2021.12517

Abstract

Hepatic ischemia/reperfusion (I/R) injury (HIRI) often occurs following tissue resection, hemorrhagic shock or transplantation surgery. Previous investigations showed that sevoflurane (Sevo), an inhalation anesthetic, had protective properties against different organ damage in animal models including HIRI. This study is aimed to investigate the underlying mechanisms involved in the protective effects of Sevo on HIRI. The present study results showed that treatment with Sevo improved histologic damage, inflammatory response, oxidative stress and apoptosis after hepatic I/R, indicating the protective role of Sevo against liver I/R injury. Importantly, in order to determine the molecular mechanism of Sevo in HIRI, the focus of the study was on microRNA (miR) regulation. By retrieving the microarray data in the Gene Expression Omnibus dataset (GSE72315), miR‑218‑5p was found to be significantly downregulated by Sevo. Moreover, miR‑218‑5p overexpression using agomiR‑218‑5p reversed the protective roles of Sevo against HIRI. Furthermore, GAB2, a positive regulator of PI3K/AKT signaling pathway, was found as a target gene of miR‑218‑5p. It was also found that the Sevo‑mediated protective effects may be dependent on the activation of GAB2/PI3K/AKT. Collectively, these data revealed that Sevo alleviated HIRI in mice by restraining apoptosis, relieving oxidative stress and inflammatory response through the miR‑218‑5p/GAB2/PI3K/AKT pathway, which helps in understanding the novel mechanism of the hepatic‑protection of Sevo.

Keywords: GAB2/PI3K/AKT pathway; hepatic ischemia/reperfusion injury; inflammatory response and apoptosis; microRNA‑218‑5p; sevoflurane

References

  1. Free Radic Biol Med. 2012 Sep 1;53(5):1123-38 - PubMed
  2. JCI Insight. 2019 Nov 14;4(22): - PubMed
  3. World J Gastroenterol. 2013 Mar 21;19(11):1683-98 - PubMed
  4. Biosci Biotechnol Biochem. 2020 Jun;84(6):1123-1130 - PubMed
  5. Anesthesiology. 1996 Oct;85(4):794-807; discussion 27A - PubMed
  6. Mol Immunol. 2016 Apr;72:1-8 - PubMed
  7. Eur J Pharmacol. 2003 Mar 28;465(1-2):163-70 - PubMed
  8. Eur Rev Med Pharmacol Sci. 2018 Aug;22(16):5295-5304 - PubMed
  9. Am J Transplant. 2015 Jan;15(1):76-87 - PubMed
  10. Sci Rep. 2014 Dec 04;4:7317 - PubMed
  11. Acta Pharmacol Sin. 2019 Jan;40(1):35-45 - PubMed
  12. Transplant Proc. 2017 Nov;49(9):2188-2193 - PubMed
  13. J Signal Transduct. 2012;2012:329635 - PubMed
  14. Biomed Pharmacother. 2016 Dec;84:1126-1136 - PubMed
  15. Int J Immunopathol Pharmacol. 2016 Jun;29(2):300-7 - PubMed
  16. Br J Anaesth. 1997 Jul;79(1):88-96 - PubMed
  17. Eur J Pharmacol. 2018 Sep 15;835:1-10 - PubMed
  18. Biochim Biophys Acta. 2014 Oct;1837(10):1790-800 - PubMed
  19. Exp Mol Med. 2018 Sep 5;50(9):1-16 - PubMed
  20. J Anesth. 2019 Jun;33(3):390-398 - PubMed
  21. J Cell Biochem. 2018 Dec;119(12):10376-10383 - PubMed
  22. Exp Cell Res. 2020 Sep 1;394(1):112128 - PubMed
  23. Biochem Pharmacol. 2017 Apr 15;130:83-92 - PubMed
  24. Liver Transpl. 2016 Dec;22(12):1697-1709 - PubMed
  25. Am J Physiol Cell Physiol. 2018 Sep 1;315(3):C380-C388 - PubMed
  26. Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G15-26 - PubMed
  27. J Pharmacol Exp Ther. 2010 Jun;333(3):736-47 - PubMed
  28. Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1770-1775 - PubMed
  29. Can J Physiol Pharmacol. 2015 Nov;93(11):999-1005 - PubMed
  30. Hepatology. 2011 Nov;54(5):1767-76 - PubMed
  31. Ann Thorac Surg. 2017 May;103(5):1578-1586 - PubMed
  32. Oncol Rep. 2020 Nov;44(5):1961-1970 - PubMed
  33. Dig Liver Dis. 2020 Aug;52(8):895-904 - PubMed
  34. Int J Clin Exp Pathol. 2015 Oct 01;8(10):13114-9 - PubMed
  35. Br J Cancer. 2007;96 Suppl:R40-4 - PubMed
  36. Brain Res Bull. 2019 Jan;144:140-148 - PubMed
  37. Chem Biol Interact. 2020 May 1;322:109027 - PubMed
  38. Int J Mol Med. 2016 Mar;37(3):851-8 - PubMed
  39. Mol Cancer Res. 2012 Oct;10(10):1265-70 - PubMed
  40. Dig Dis Sci. 2019 Aug;64(8):2177-2186 - PubMed
  41. Biomed Pharmacother. 2019 May;113:108697 - PubMed
  42. Transplant Rev (Orlando). 2012 Apr;26(2):103-14 - PubMed
  43. Acta Oncol. 2013 Nov;52(8):1739-50 - PubMed
  44. Life Sci. 2020 Oct 15;259:118162 - PubMed
  45. Methods. 2001 Dec;25(4):402-8 - PubMed
  46. PLoS One. 2015 Aug 11;10(8):e0134666 - PubMed
  47. Exp Ther Med. 2019 Apr;17(4):2632-2640 - PubMed
  48. J Nutr Biochem. 2012 Sep;23(9):1113-20 - PubMed
  49. Sci Rep. 2017 Mar 21;7:44785 - PubMed
  50. J Cell Biochem. 2019 Sep;120(9):15494-15505 - PubMed
  51. Cell Biol Int. 2017 May;41(5):495-504 - PubMed
  52. Med Sci Monit. 2020 Feb 02;26:e920101 - PubMed
  53. Anesth Analg. 2008 Mar;106(3):830-7, table of contents - PubMed
  54. Biomed Pharmacother. 2018 Jun;102:153-159 - PubMed
  55. Cell. 2004 Jan 23;116(2):281-97 - PubMed
  56. J Biochem. 2019 Nov 1;166(5):415-421 - PubMed
  57. Pharmacology. 2020;105(3-4):231-242 - PubMed
  58. Chem Biol Interact. 2019 Aug 1;308:332-338 - PubMed
  59. Anesth Analg. 2018 Oct;127(4):1058-1065 - PubMed
  60. Free Radic Res. 2010 Aug;44(8):854-63 - PubMed
  61. Br J Anaesth. 2008 Feb;100(2):190-4 - PubMed

Publication Types